Congressional Testimony
This section includes testimony by FDA officials before House and Senate Committees and Subcommittees. For testimony from previous years, see the FDA Archive.
March 2019
- 03/28/2019
President's Fiscal Year 2020 Budget Request for FDA
Scott Gottlieb, M.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
February 2019
- 02/27/2019
Status of Operations Hearing
Scott Gottlieb, M.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
October 2018
- 10/02/2018
Stopping the Poison Pills: Combatting the Trafficking of Illegal Fentanyl From China Daniel G. Burke, Senior Operations Manager, Cybercrime Investigations Unit, Office of Criminal Investigations, FDA Office of Regulatory Affairs, before the Senate Caucus on International Narcotics Control
July 2018
- 07/25/2018
Implementing The 21st Century Cures Act: A 2018 Update From FDA And NIH Scott Gottlieb, M.D., before the House Committee on Energy and Commerce, Subcommittee Health
June 2018
- 06/15/2018
The State Of U.S. Public Health Biopreparedness: Responding To Biological Attacks, Pandemics, And Emerging Infectious Disease Outbreaks
RADM Denise Hinton before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 06/06/2018
Examining the Reauthorization of the Pandemic and All-Hazards Preparedness Act
Anna Abram before the House Committee on Energy and Commerce, Subcommittee Health
April 2018
- 04/24/2018
The President's Fiscal Year 2019 Budget Request - Senate Testimony
Scott Gottlieb, M.D., before the Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 04/17/2018
President's Fiscal Year 2019 Budget Request for FDA - House Testimony
Scott Gottlieb, M.D., before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
March 2018
- 03/21/2018
Combatting the Opioid Crisis: Prevention and Public Health Solutions
Scott Gottlieb, M.D. before the Subcommittee on Health, House Energy and Commerce Committee - 03/14/2018
Reauthorization of Animal Drug User Fees: ADUFA and AGDUFA Steven Solomon, D.V.M, before the House Subcommittee on Health, Committee on Energy and Commerce - 03/08/2018
Examining U.S. Public Health Preparedness for And Response Efforts to Seasonal Influenza Scott Gottlieb, M.D. before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
February 2018
- 02/13/2018
Improving Animal Health: Reauthorization of FDA Animal Drug User Fees Steven Solomon, D.V.M, MPH, before the Senate Committee on Health, Education, Labor, and Pensions
January 2018
- 01/30/2018
Examining Implementation Of The Compounding Quality Act Scott Gottlieb, M.D., before the Subcommittee On Health, House Committee On Energy And Commerce - 01/19/2018
Safety of the U.S. Food Supply: Continuing Concerns Over The Food and Drug Administration's Food Recall Process Douglas W. Stearn, J.D., before the House Subcommittee on Oversight and Investigations, Committee on Energy and Commerce - 01/17/2018
Facing 21st Century Public Health Threats: Our Nation's Preparedness and Response Capabilities, Part I Testimony of FDA Commissioner Scott Gottlieb before the Senate Committee on Health, Education, Labor and Pensions, January 17, 2018